Westfuller Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.3K Buy
874
+533
+156% +$30.6K 0.02% 306
2026
Q1
$20.7K Buy
341
+78
+30% +$4.55K 0.01% 349
2025
Q4
$14.2K Buy
263
+71
+37% +$3.42K 0.01% 417
2025
Q3
$8.67K Buy
+192
New +$8.97K ﹤0.01% 471

Other funds holding BMY

Westfuller Advisors's BMY Position: Q2 2026 in Review

Westfuller Advisors increased its Bristol-Myers Squibb (BMY) stake by 156% in Q2 2026, buying an estimated $30.6K and bringing the position to 874 shares worth $50.3K. The position accounts for 0.02% of the portfolio, ranked #306.

Westfuller Advisors first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. 1,157 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Westfuller Advisors held 874 shares of Bristol-Myers Squibb worth $50.3K as of Q2 2026.
  • Westfuller Advisors bought 533 Bristol-Myers Squibb shares in Q2 2026, an estimated $30.6K.
  • Bristol-Myers Squibb made up 0.02% of Westfuller Advisors's portfolio in Q2 2026, its #306 holding.
  • Westfuller Advisors first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • 1,157 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.